These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1380095)

  • 1. Interactions of polyomavirus middle T with the SH2 domains of the pp85 subunit of phosphatidylinositol-3-kinase.
    Yoakim M; Hou W; Liu Y; Carpenter CL; Kapeller R; Schaffhausen BS
    J Virol; 1992 Sep; 66(9):5485-91. PubMed ID: 1380095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine phosphorylation is a signal for the trafficking of pp85, an 85-kDa phosphorylated polypeptide associated with phosphatidylinositol kinase activity.
    Cohen B; Yoakim M; Piwnica-Worms H; Roberts TM; Schaffhausen BS
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4458-62. PubMed ID: 1693771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85.
    Myers MG; Backer JM; Sun XJ; Shoelson S; Hu P; Schlessinger J; Yoakim M; Schaffhausen B; White MF
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10350-4. PubMed ID: 1332046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of pp85, a target of oncogenes and growth factor receptors.
    Cohen B; Liu YX; Druker B; Roberts TM; Schaffhausen BS
    Mol Cell Biol; 1990 Jun; 10(6):2909-15. PubMed ID: 2160590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional interaction between the SH2 domain of Fyn and tyrosine 324 of hamster polyomavirus middle-T antigen.
    Dunant NM; Messerschmitt AS; Ballmer-Hofer K
    J Virol; 1997 Jan; 71(1):199-206. PubMed ID: 8985339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange.
    Felder S; Zhou M; Hu P; Ureña J; Ullrich A; Chaudhuri M; White M; Shoelson SE; Schlessinger J
    Mol Cell Biol; 1993 Mar; 13(3):1449-55. PubMed ID: 7680095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
    Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide.
    Domchek SM; Auger KR; Chatterjee S; Burke TR; Shoelson SE
    Biochemistry; 1992 Oct; 31(41):9865-70. PubMed ID: 1382595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyomavirus middle-T antigen associates with the kinase domain of Src-related tyrosine kinases.
    Dunant NM; Senften M; Ballmer-Hofer K
    J Virol; 1996 Mar; 70(3):1323-30. PubMed ID: 8627648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Src homology 2 domain of the protein-tyrosine kinase p56lck mediates both intermolecular and intramolecular interactions.
    Amrein KE; Panholzer B; Flint NA; Bannwarth W; Burn P
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10285-9. PubMed ID: 7694287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR structure of the N-SH2 of the p85 subunit of phosphoinositide 3-kinase complexed to a doubly phosphorylated peptide reveals a second phosphotyrosine binding site.
    Weber T; Schaffhausen B; Liu Y; Günther UL
    Biochemistry; 2000 Dec; 39(51):15860-9. PubMed ID: 11123912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis of a phosphatidylinositol 3-kinase SH2 domain reveals determinants of specificity.
    Yoakim M; Hou W; Songyang Z; Liu Y; Cantley L; Schaffhausen B
    Mol Cell Biol; 1994 Sep; 14(9):5929-38. PubMed ID: 8065326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An 81 kd protein complexed with middle T antigen and pp60c-src: a possible phosphatidylinositol kinase.
    Courtneidge SA; Heber A
    Cell; 1987 Sep; 50(7):1031-7. PubMed ID: 2441879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src.
    Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS
    Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc.
    Dilworth SM; Brewster CE; Jones MD; Lanfrancone L; Pelicci G; Pelicci PG
    Nature; 1994 Jan; 367(6458):87-90. PubMed ID: 7509037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity.
    Kaplan DR; Whitman M; Schaffhausen B; Pallas DC; White M; Cantley L; Roberts TM
    Cell; 1987 Sep; 50(7):1021-9. PubMed ID: 2441878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation.
    Glenn GM; Eckhart W
    J Virol; 1993 Apr; 67(4):1945-52. PubMed ID: 7680388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation.
    Ong SH; Dilworth S; Hauck-Schmalenberger I; Pawson T; Kiefer F
    EMBO J; 2001 Nov; 20(22):6327-36. PubMed ID: 11707404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal.
    Ladbury JE; Lemmon MA; Zhou M; Green J; Botfield MC; Schlessinger J
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3199-203. PubMed ID: 7536927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
    Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
    Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.